Balantidiasis Complicating a Case of Ulcerative Colitis

Kamberoglou, D.; Savva, S.; Adraskelas, N.; Yannitsiotis, A.; Cocca, E.
June 1990
American Journal of Gastroenterology;Jun1990, Vol. 85 Issue 6, p765
Academic Journal
Discusses a study on the possible effect of Balantidium coli on Ulcerative colitis. Overview of a case of a woman who was diagnosed with ulcerative proctitis; Description of the Balantidium coli; Result of the study.


Related Articles

  • High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial. Howarth, G.F.; Robinson, M.H.E.; Jenkins, D.; Hardcastle, J.D.; Logan, R.F.A. // American Journal of Gastroenterology;Mar2002, Vol. 97 Issue 3, p690 

    OBJECTIVES:Inflammatory bowel disease (IBD) is usually diagnosed as a result of symptoms but occasionally is found during investigation for other conditions. An earlier report from Nottingham had found a high prevalence of previously undetected “asymptomatic” IBD detected as a result...

  • Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis. Fuentes-Páez, Graciana; Martínez-Osorio, Hernán; Herreras, José M.; Calonge, Margarita // International Journal of Colorectal Disease;Mar2007, Vol. 22 Issue 3, p333 

    We report a case of subretinal fibrosis and panuveitis syndrome as an extraintestinal manifestation of ulcerative colitis. We present an interventional case report of a 40-year-old female patient with inactive ulcerative colitis referred to our center for refractory uveitis in her right eye. She...

  • Omega-3 fatty acids in the maintenance of ulcerative colitis. Papadia, Cinzia; Coruzzi, Alessandro; Montana, Chiara; Di Mario, Francesco; Franzè, Angelo; Forbes, Alastair // JRSM Shorts;Jun2010, Vol. 1 Issue 1, p1 

    The article presents a case study of a 38-year-old Caucasian woman with ulcerative colitis. The patient was referred to the inflammatory bowel disease (IBD) clinic of Parma University Hospital due to the exacerbation of her ulcerative colitis. Omega-3 unsaturated fatty acid therapy was given to...

  • The Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis. Wu, Ping; Guo, Yonggao; Jia, Fangyuan; Wang, Xiuli // Cell Biochemistry & Biophysics;May2015, Vol. 72 Issue 1, p103 

    To study the therapeutic effect of Armillarisin A on patients with ulcerative colitis (UC) and on serum IL-1β and IL-4, sixty patients with UC were randomly divided into three groups: Armillarisin A treatment group (Group I), Armillarisin-combined hormone therapy group (Group II), and...

  • Antineutrophil cytoplasmic antibody and the gastroenterologist. Dickey, William; McMillan, Stanley // Journal of the Royal Society of Medicine;Sep1992, Vol. 85 Issue 9, p518 

    The article discusses the antineutrophil cytoplasmic antibody (ANCA) as a diagnostic test. It describes the ANCA associated with ulcerative colitis. It describes ulcerative colitis as an autoimmune disorder. The ANCA in ulcerative colitis cannot be used to monitor disease activity and response...

  • The Month of Birth is Linked to the Risk of Crohn's Disease in the Israeli Population. Chowers, Yehuda; Odes, Shmuel; Bujanover, Yoram; Eliakim, Rami; Bar Meir, Simon; Avidan, Benjamin // American Journal of Gastroenterology;Oct2004, Vol. 99 Issue 10, p1974 

    OBJECTIVE: The main objective is to study whether the month of birth is associated with the development of Crohn's disease (CD) in the Israeli Jewish population.BACKGROUND: It was suggested that perinatal exposure to infectious agents may have a role in the pathogenesis of CD. Due to the...

  • Diagnostic Value of Anti-Saccharomyces cerevisiae and Antineutrophil Cytoplasmic Autoantibodies in Inflammatory Bowel Disease. Peeters, Marc; Joossens, Sofie; Vermeire, Severine; Vlietinck, Robert; Bossuyt, Xavier; Rutgeerts, Paul // American Journal of Gastroenterology;Mar2001, Vol. 96 Issue 3, p730 

    OBJECTIVES: Correct diagnosis of inflammatory bowel disease (IBD), especially the differentiation between Crohn's disease (CD) and ulcerative colitis (UC), is highly important toward treatment and prognosis. Serological markers are noninvasive diagnostic tools that could be of value in...

  • Clinical Utility of Serodiagnostic Testing in Suspected Pediatric Inflammatory Bowel Disease. Dubinsky, Marla C.; Ofman, Joshua J.; Urman, Marnina; Targan, Stephan R.; Seidman, Ernest G. // American Journal of Gastroenterology;Mar2001, Vol. 96 Issue 3, p758 

    OBJECTIVES: Confronted with nonspecific symptoms, accurate screening tests would be useful to clinicians to distinguish between functional childhood disorders and inflammatory bowel disease (IBD), thus avoiding invasive diagnostic testing. Traditional ulcerative colitis-specific perinuclear...

  • Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. Michael, Mandel; Bálint, Anita; Lovász, Barbara; Gulácsi, László; Strbák, Bálint; Golovics, Petra; Farkas, Klaudia; Kürti, Zsuzsanna; Szilágyi, Blanka; Mohás, Anna; Molnár, Tamás; Lakatos, Péter // European Journal of Health Economics;May2014 Supplement, Vol. 15, p121 

    Background and aims: To assess work disability (WD) rates in an inflammatory bowel disease (IBD) cohort involving patients with Crohn's disease (CD) or ulcerative colitis (UC) cohort and to identify possible clinical or demographic factors associated with WD. To our knowledge, this is the first...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics